MCIA
AVNS

Mountain Capital Investment Advisors’s Avanos Medical AVNS Stock Holding History

Mountain Capital Investment Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9
Closed – – 64
2017
Q3 		$0 Hold
9
– – ﹤0.01% 501
2017
Q2 		$0 Buy
+9
New +$340 ﹤0.01% 513

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mountain Capital Investment Advisors's AVNS Position: Q4 2017 in Review

Mountain Capital Investment Advisors sold out of Avanos Medical (AVNS) in Q4 2017, closing a stake of 9 shares.

Mountain Capital Investment Advisors first reported a position in AVNS in Q2 2017 and held it in 2 quarters. The position peaked at $0 in Q3 2017. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2017.

  • Mountain Capital Investment Advisors reported no remaining Avanos Medical position as of Q4 2017 after selling out during the quarter.
  • Mountain Capital Investment Advisors sold 9 Avanos Medical shares in Q4 2017.
  • Mountain Capital Investment Advisors first reported a position in Avanos Medical in Q2 2017 and held it in 2 quarters.
  • Mountain Capital Investment Advisors's Avanos Medical position peaked at $0 in Q3 2017.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2017.

Based on Mountain Capital Investment Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.